je.st
news
Celgene Will Buy Drug Developer Receptos for $7.32 Billion
2015-07-15 00:23:18| Biotech - Topix.net
Cancer drug maker Celgene says it will buy drug developer Receptos for $7.32 billion cash, gaining a drug Receptos is studying as a treatment for multiple sclerosis and ulcerative colitis. Celgene agreed to pay $232 per share for Receptos, and the companies valued the deal at $7.2 billion excluding Receptos' cash on hand.
Tags: buy
drug
developer
billion
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||